Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi,et al . Thyroid 2021;31(5):821–828;doi: 10.1089/thy.2020.0269